Related Experiment Video

Updated: Aug 21, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

[Amphotericin B: the end of an era]

A M L Oude Lashof1, B J Kullberg

  • 1Universitair Medisch Centrum St Radboud, Nijmeegs Universitair Centrum voor Infectieziekten, afd. Algemeen Interne Geneeskunde AIG-541, Postbus 9101, 6500 HB Nijmegen.

Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2004
PubMed

Insights

Lipid-associated amphotericin B formulations offer reduced nephrotoxicity compared to conventional amphotericin B. However, their efficacy is not clearly superior, and newer antifungals limit amphotericin B

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • Amphotericin B has been a primary treatment for invasive fungal infections for 45 years.
  • Severe toxicity led to the development of lipid-associated formulations.
  • Comparative efficacy data for lipid formulations are limited.

Discussion:

  • Lipid-associated amphotericin B exhibits significantly reduced nephrotoxicity versus the conventional form.
  • Infusion-related toxicities vary considerably among different lipid formulations.
  • The advent of azoles and echinocandins has diminished the role of amphotericin B.

Key Insights:

  • Lipid formulations of amphotericin B demonstrate improved safety profiles, particularly regarding kidney toxicity.
  • Efficacy of lipid-associated amphotericin B is not definitively proven to be superior to conventional forms.
  • Current antifungal options have relegated amphotericin B to niche applications.

Outlook:

  • Further research is needed to clarify the comparative efficacy of lipid formulations.
  • Understanding and managing infusion-related toxicities remains crucial for clinical use.
  • Amphotericin B's role is likely to remain limited to specific, rare mycoses.

More Related Videos

Establishing Fungal Entomopathogens as Endophytes: Towards Endophytic Biological Control15:14

Establishing Fungal Entomopathogens as Endophytes: Towards Endophytic Biological Control

Published on: April 11, 2013

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...